Stephen Mitchener - Net Worth and Insider Trading
Stephen Mitchener Net Worth
The estimated net worth of Stephen Mitchener is at least $94,952 dollars as of 2024-09-20. Stephen Mitchener is the SVP, Chief Business Officer of Karyopharm Therapeutics Inc and owns about 128,313 shares of Karyopharm Therapeutics Inc (KPTI) stock worth over $94,952. Details can be seen in Stephen Mitchener's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Stephen Mitchener has not made any transactions after 2023-03-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Stephen Mitchener
Stephen Mitchener Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stephen Mitchener owns 2 companies in total, including Axcella Health Inc (AXLA) , and Karyopharm Therapeutics Inc (KPTI) .
Click here to see the complete history of Stephen Mitchener’s form 4 insider trades.
Insider Ownership Summary of Stephen Mitchener
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AXLA | Axcella Health Inc | 2019-05-08 | Sr VP & Chief Business Officer |
| KPTI | Karyopharm Therapeutics Inc | 2023-03-01 | SVP & Chief Business Officer |
Stephen Mitchener Latest Holdings Summary
Stephen Mitchener currently owns a total of 1 stock. Stephen Mitchener owns 128,313 shares of Karyopharm Therapeutics Inc (KPTI) as of March 1, 2023, with a value of $94,952.
Latest Holdings of Stephen Mitchener
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc | 2023-03-01 | 128,313 | 0.74 | 94,952 |
Holding Weightings of Stephen Mitchener
Stephen Mitchener Form 4 Trading Tracker
According to the SEC Form 4 filings, Stephen Mitchener has made a total of 3 transactions in Karyopharm Therapeutics Inc (KPTI) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Karyopharm Therapeutics Inc is the sale of 6,357 shares on March 1, 2023, which brought Stephen Mitchener around $19,262.
Insider Trading History of Stephen Mitchener
- 1
Stephen Mitchener Trading Performance
Stephen Mitchener Ownership Network
Stephen Mitchener Owned Company Details
What does Axcella Health Inc do?
Who are the key executives at Axcella Health Inc?
Stephen Mitchener is the Sr VP & Chief Business Officer of Axcella Health Inc. Other key executives at Axcella Health Inc include Senior Vice President & CIPO Paul Fehlner , director & President and CEO William Hinshaw , and 10 percent owner L.p. Fpa, .
Axcella Health Inc (AXLA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Axcella Health Inc (AXLA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Axcella Health Inc (AXLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Axcella Health Inc (AXLA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Axcella Health Inc Insider Transactions
Stephen Mitchener Mailing Address
Above is the net worth, insider trading, and ownership report for Stephen Mitchener. You might contact Stephen Mitchener via mailing address: C/o Axcella Health Inc., 840 Memorial Drive, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
